These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 23567343)

  • 21. Efficacy of live virus vaccines against infectious laryngotracheitis assessed by polymerase chain reaction-restriction fragment length polymorphism.
    Han MG; Kim SJ
    Avian Dis; 2003; 47(2):261-71. PubMed ID: 12887186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation onto the correlation between systemic antibodies to surface glycoproteins of infectious laryngotracheitis virus (ILTV) and protective immunity.
    Sabir AJ; Adams TE; O'Rourke D; Devlin JM; Noormohammadi AH
    Vet Microbiol; 2019 Jan; 228():252-258. PubMed ID: 30593375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In ovo vaccination of commercial broilers with a glycoprotein J gene-deleted strain of infectious laryngotracheitis virus.
    Mashchenko A; Riblet SM; Zavala G; García M
    Avian Dis; 2013 Jun; 57(2 Suppl):523-31. PubMed ID: 23901771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the safety and protective efficacy of vaccination with glycoprotein-G-deficient infectious laryngotracheitis virus delivered via eye-drop, drinking water or aerosol.
    Devlin JM; Browning GF; Gilkerson JR; Fenton SP; Hartley CA
    Avian Pathol; 2008 Feb; 37(1):83-8. PubMed ID: 18202954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies of infectious laryngotracheitis vaccines: immunity in broilers.
    Andreasen JR; Glisson JR; Goodwin MA; Resurreccion RS; Villegas P; Brown J
    Avian Dis; 1989; 33(3):516-23. PubMed ID: 2549939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuated infectious laryngotracheitis virus vaccines differ in their capacity to establish latency in the trigeminal ganglia of specific pathogen free chickens following eye drop inoculation.
    Thilakarathne DS; Coppo MJC; Hartley CA; Diaz-Méndez A; Quinteros JA; Fakhri O; Vaz PK; Devlin JM
    PLoS One; 2019; 14(3):e0213866. PubMed ID: 30921344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the replication and transmissibility of an infectious laryngotracheitis virus vaccine delivered via eye-drop or drinking-water.
    Coppo MJ; Devlin JM; Noormohammadi AH
    Avian Pathol; 2012; 41(1):99-106. PubMed ID: 22845327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Horizontal transmission dynamics of a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus and the effect of vaccination on transmission of virulent virus.
    Devlin JM; Hartley CA; Gilkerson JR; Coppo MJ; Vaz P; Noormohammadi AH; Wells B; Rubite A; Dhand NK; Browning GF
    Vaccine; 2011 Aug; 29(34):5699-704. PubMed ID: 21689710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of infectious laryngotracheitis vaccines: immunity in layers.
    Andreasen JR; Glisson JR; Goodwin MA; Resurreccion RS; Villegas P; Brown J
    Avian Dis; 1989; 33(3):524-30. PubMed ID: 2549940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of chickens from Newcastle disease and infectious laryngotracheitis with a recombinant fowlpox virus co-expressing the F, HN genes of Newcastle disease virus and gB gene of infectious laryngotracheitis virus.
    Sun HL; Wang YF; Tong GZ; Zhang PJ; Miao DY; Zhi HD; Wang M; Wang M
    Avian Dis; 2008 Mar; 52(1):111-7. PubMed ID: 18459306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection induced by commercially available live-attenuated and recombinant viral vector vaccines against infectious laryngotracheitis virus in broiler chickens.
    Vagnozzi A; Zavala G; Riblet SM; Mundt A; García M
    Avian Pathol; 2012; 41(1):21-31. PubMed ID: 22845318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of immunological responses to a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus.
    Devlin JM; Viejo-Borbolla A; Browning GF; Noormohammadi AH; Gilkerson JR; Alcami A; Hartley CA
    Vaccine; 2010 Feb; 28(5):1325-32. PubMed ID: 19932672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Commercial Vaccines and Vaccination Strategies Against Infectious Laryngotracheitis: What We Have Learned and Knowledge Gaps That Remain.
    García M; Zavala G
    Avian Dis; 2019 Jun; 63(2):325-334. PubMed ID: 31251534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-protective immune responses between genotypically distinct lineages of infectious laryngotracheitis viruses.
    Lee SW; Markham PF; Coppo MJ; Legione AR; Shil NK; Quinteros JA; Noormohammadi AH; Browning GF; Hartley CA; Devlin JM
    Avian Dis; 2014 Mar; 58(1):147-52. PubMed ID: 24758128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of vaccination against infectious laryngotracheitis (ILT) with recombinant herpesvirus of turkey (rHVT-LT) and chicken embryo origin (CEO) vaccines applied alone or in combination.
    Maekawa D; Riblet SM; Newman L; Koopman R; Barbosa T; García M
    Avian Pathol; 2019 Dec; 48(6):573-581. PubMed ID: 31304770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycoprotein G deficient infectious laryngotracheitis virus is a candidate attenuated vaccine.
    Devlin JM; Browning GF; Hartley CA; Gilkerson JR
    Vaccine; 2007 May; 25(18):3561-6. PubMed ID: 17316926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuation and Protection Efficacy of a Recombinant Infectious Laryngotracheitis Virus (ILTV) Depleted of Open Reading Frame C (ΔORFC) when Delivered in ovo.
    Schneiders GH; Riblet SM; García M
    Avian Dis; 2018 Jun; 62(2):143-151. PubMed ID: 29944395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of route of vaccination on the prevention of infectious laryngotracheitis in commercial egg-laying chickens.
    Fulton RM; Schrader DL; Will M
    Avian Dis; 2000; 44(1):8-16. PubMed ID: 10737639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection Efficacy of Recombinant HVT-ND-LT and the Live Attenuated Tissue Culture Origin Vaccines Against Infectious Laryngotracheitis Virus When Administered Individually or in Combination.
    Becerra R; Maekawa D; García M
    Avian Dis; 2023 Jun; 67(2):145-152. PubMed ID: 37556293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection Induced in Broiler Chickens following Drinking-Water Delivery of Live Infectious Laryngotracheitis Vaccines against Subsequent Challenge with Recombinant Field Virus.
    Korsa MG; Browning GF; Coppo MJ; Legione AR; Gilkerson JR; Noormohammadi AH; Vaz PK; Lee SW; Devlin JM; Hartley CA
    PLoS One; 2015; 10(9):e0137719. PubMed ID: 26366738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.